Lifetrack Newsletter

Neptune Technologies begins trading on NASDAQ

First Canadian CRO to expand clinical trial management operations to India

Laval, Québec, CANADA – Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB) announced that its shares began trading on the NASDAQ Stock Market under the symbol NEPT on Monday, August 13 at the opening bell. Neptune Technologies & Bioressources (NTB) extracts, scientifically validates, and markets scientifically validated health ingredients extracted from marine biomasses; the Company currently provides the world’s only FDA-allowed oil from krill.

COMPANY NAME: NEPTUNE TECHNOLOGIES & BIORESSOURCES
STOCK SYMBOL: NEPT
STOCK MARKET: NASDAQ CAPITAL MARKET START TRADING AUGUST 13, 2007 OPENING BELL

The TSX.V has not reviewed and does not accept responsibility for the adequacy and accuracy of this news release.

About Neptune Technologies & Bioressources, Inc.
Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract™). Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the health and wellness market.

Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.

For further information contact:

Source: Neptunebiotech.com and BioQuebec.com